Skip to content
Female scientist in a laboratory carefully dispensing liquid into test tubes.

Unleashing the Power of Aptamarkers: A New Frontier in Disease Management

Revolutionary Biomarker Discovery: Aptamarker allows agnostic screening for biomarkers, transforming disease understanding. Enables patient stratification in clinical trials for enhanced safety and precision medicine. Predictive and Precise Drug Development: Predicts side effects and translates animal model findings for safer drug development. Maps drug binding sites… Read More »Unleashing the Power of Aptamarkers: A New Frontier in Disease Management

Disease Detection

Revolutionizing Disease Detection: NeoVentures Biotechnology’s Aptamarker Platform

Aptamarker Paradigm Shift: NeoVentures Biotechnology’s Aptamarker platform challenges the traditional approach to biomarker discovery by eliminating the need to first understand the cause of a disease. Revolutionizing Healthcare: Aptamarker enables the identification of disease biomarkers without the constraints of unraveling disease causation, leading to faster… Read More »Revolutionizing Disease Detection: NeoVentures Biotechnology’s Aptamarker Platform

Microscope and array of test tubes on a laboratory bench.

Revolutionizing Drug Level Detection: NeoVentures’ Neomer Aptamers Take the Lead

NeoVentures’ Neomer aptamer selection method replaces the traditional SELEX process, offering a closed and reproducible space for aptamer development, ensuring consistency in drug level detection. The inclusion of an in-silico immune tolerance step enhances Neomer aptamers’ specificity and selectivity, making them more precise in detecting… Read More »Revolutionizing Drug Level Detection: NeoVentures’ Neomer Aptamers Take the Lead

dropper and Petry dish

Aptamarker Use Case: Breaking Barriers – Aptamarkers Pave the Way for Seamless Translation from Animal Trials to Human Trials

Immune Tolerance Advantage of Aptamarkers: Aptamarkers overcome immune tolerance issues in traditional antibody development. Aptamarkers vs. Antibodies: A Quantitative Advantage: Broader recognition spectrum aligns the biomarker landscape in animal models more closely with the human context. Training Aptamarkers in Animal Trials: Aptamarkers can be trained… Read More »Aptamarker Use Case: Breaking Barriers – Aptamarkers Pave the Way for Seamless Translation from Animal Trials to Human Trials

image of an aptamer under a microscope

Aptamarker Use Case: Enhancing Clinical Trials with Aptamarker Precision – Tailoring Inclusion and Exclusion Criteria

NeoVentures Biotechnology’s Aptamarker platform revolutionizes clinical trials by introducing personalized and predictive inclusion and exclusion criteria. Aptamarkers are trained using biological samples and participants’ treatment responses, enabling a cost-effective qPCR test for screening individuals entering clinical trials. The predictive capabilities of Aptamarkers allow researchers to… Read More »Aptamarker Use Case: Enhancing Clinical Trials with Aptamarker Precision – Tailoring Inclusion and Exclusion Criteria

realistic molecule

The Specificity of Aptamers: Can They Selectively Bind to a Single Compound?

Aptamers are engineered molecules that can bind to specific target compounds with high affinity and selectivity, making them valuable tools in various applications. Achieving absolute specificity, or binding to a single compound exclusively, is challenging due to the structural similarities among molecules. However, aptamers can… Read More »The Specificity of Aptamers: Can They Selectively Bind to a Single Compound?

Close up of a realistic display of aptamers

Aptamers: Revolutionizing Diagnostics in the Next Generation

Aptamers are synthetic, single-stranded DNA, RNA, or peptide molecules with high specificity and affinity for a wide range of target molecules, making them valuable in diagnostics. Advantages of aptamers in diagnostics include high specificity, versatility for various target types, and stability under different environmental conditions.… Read More »Aptamers: Revolutionizing Diagnostics in the Next Generation

realistic image of antibodies vs aptamers

A Therapeutic Battle: Antibodies vs. Aptamers

In the realm of modern medicine, researchers and scientists are continually exploring innovative ways to combat diseases and improve the quality of life for patients. Two emerging contenders in the therapeutic arena are antibodies and aptamers. These molecular warriors hold immense potential in diagnosing and… Read More »A Therapeutic Battle: Antibodies vs. Aptamers

en_CAEnglish